Supplemental Experimental Procedures
Plasmids pMSCV-IRE1α-HA encoding WT human IRE1α (Hetz et al., 2006) was provided by Dr. C. Hetz (University of Chile). IRE1α mutants D123P, K599A and P830L were previously generated and described (Xue et al., 2011) . CMV-GFP-NMHCII-B was purchased from Addgene Inc. CMV-GFP-NMHCII-B R709C was previously described (Kim et al., 2012) . pcDNA3-Flag-mouse XBP1s was described previously (Chen and Qi, 2010) .
Transfection
Transfections of HEK293T were performed as we recently described (Chen and Qi, 2010) . Transfections of MEFs were performed using Lipofectamine 2000 (Invitrogen) per supplier's protocol. Cells were snap-frozen in liquid nitrogen 24-36 h post-transfection followed by Western blot. 
Antibodies for

IRE1 Immunopurification and Mass Spectrometry
IRE1 -/-MEFs stably expressing human pMSCV-IRE1 -HA were treated with 300 nM Tg for 2 h. Cells were harvested in lysis buffer (150mM NaCl, 1% Triton X-100, 1mM EDTA, 50mM Tris HCl pH 7.5) supplemented with protease inhibitor cocktail (Sigma) and allowed to lyse on ice for 25 min. Cells were sonicated 10 s once with Branson Digital 250 Cell Disruptor at 10% amplitude followed by centrifugation. Supernatant was harvested and loaded on a 6% polyacrylamide SDS-PAGE gel. Gel was incubated with Coomassie Brilliant Blue (0.5 g Coomassie Brilliant Blue R-250 in 450ml methanol, 450ml MQ water, and 100ml acetic acid) with gentle rocking for 30 min at room temperature followed by 2 washes with MQ water 5 min each. Gel was destained in destaining solution (45% methanol, 45% MQ water, 10% acetic acid) that was changed every 30 min until bands could be clearly visualized. Protein bands were excised from Coomassie-stained gels and destained, and subjected to an in-gel trypsin digestion. Briefly, digestion was performed with 12.5 ng/μL of trypsin in 50 mM ammonium bicarbonate and incubated overnight at 37°C. The resultant peptides were extracted with 50% acetonitrile/5% formic acid and dried in a vacuum centrifuge. Prior to measurements, dried peptides were dissolved in 0.1% formic acid.
The peptide mixtures were analyzed by online nanoflow liquid chromatography tandem mass spectrometry (LC-MS/MS) on an Agilent 1200 quaternary HPLC system (Agilent, Palo Alto, CA) connected to an LTQ-Orbitrap mass spectrometer (Thermo Fisher Scientific) through an in-house built nanoelectrospray ion source. The peptide mixtures were pressure-loaded onto a capillary column (75-µm i.d.) packed with 15-cm of 3-µm Aqua C18 resins (Phenomenex, Ventura, CA). They were separated with a 3-hr gradient from 5% to 60% acetonitrile in 0.1% formic acid and a flow rate of 300 nL/min (through split). As peptides were eluted from the analytical column, they were electrosprayed (distal 2.5 kV spray voltage) into the mass spectrometer. MS instrument method consisted of an FT full-scan MS analysis (400-1600 m/z, 60000 resolution) followed by data-dependent MS/MS scans of the 8 most intense precursors at a 35% normalized collision energy with dynamic exclusion for 60 s. Application of mass spectrometer scan functions and HPLC solvent gradients was controlled by the Xcalibur data system (Thermo Fisher Scientific).
MS/MS spectra were extracted using RawXtract (version 1.9.9) (McDonald et al., 2004) and searched with the ProLuCID algorithm against a human UniProt database concatenated to a decoy database in which the sequence for each entry in the original database was reversed (Peng et al., 2003) . ProLuCID search results were assembled and filtered using the DTASelect (version 2.0) algorithm (Tabb et al., 2002 ) with a false positive rate below one percent.
